Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal

Psychopharmacology

Volumn 169, Issue 1, 2003, Pages 28-34

  De Souza, Ian E J ^a,b   Dawson, Niamh M ^c   Clifford, Jeremiah J ^a   Waddington, John L ^a   Meredith, Gloria E ^b,d  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Behavioural topography; Dopamine D2 receptor; Haloperidol decanoate; Orofacial movements; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

HALOPERIDOL DECANOATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; HABITUATION; LOCOMOTION; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; PRIORITY JOURNAL; TOPOGRAPHY; TREMOR; VACUOUS CHEWING MOVEMENT; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; EXPLORATORY BEHAVIOR; HALOPERIDOL; MALE; MASTICATION; MOTOR ACTIVITY; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0042375994     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1466-2     Document Type: Article

References (37)

1. Andreassen OA, Jørgensen HA (1995) The rat model of tardive dyskinesia: relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment. Life Sci 57:2263-2272
2. Andreassen OA, Finsen B, Ostergaard K, Sorensen JC, West MJ, Jørgensen HA (1999) The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats. Neuroscience 88:27-35
3. Bernardi MM, Nero JP (1979) Effects of abrupt and gradual withdrawal from long-term haloperidol treatment on open field behaviour of rats. Psychopharmacology 65:247-250
4. 3 dopamine receptor antagonists using an ethologically based approach. Psychopharmacology 136:284-290
5. 4 dopamine receptor agonists and antagonists. Neuropsychopharmacology 22:538-544
6. 1-like dopamine receptors not linked to adenylyl cyclase. Brit J Pharmacol 116:2120-2126
7. Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE (1994) Alterations in dopamine receptor and neuropeptide gene expression in striatonigral and striatopallidal neurons in rats with vacuous chewing movements induced by chronic treatment with haloperidol. Synapse 18:178-189
8. Egan MF, Ferguson J, Hyde TM (1996a) Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements. Pharmacol Biochem Behav 53:401-410
9. Egan MF, Hurd Y, Ferguson J, Bachus SE, Harold EH, Hyde TM (1996b) Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology 127:337-345
10. Ellison E, See RE (1989) Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology 98:564-566
11. Ellison E, See RE (1990) Chronic administration of typical, but not atypical neuroleptics induce persisting alterations in rest-activity cycles in rats. Pharmacol Biochem Behav 36:807-811
12. Ellison E, See RE, Levin E, Kinney J (1987) Tremorous mouth movements in rats administered chronic neuroleptics. Psychopharmacology 92:122-126
13. Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69:19-25
14. Gunne LM, Haggstrom J-E (1983) Reduction in nigral glutamic acid decarhoxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology 81:191-194
15. Jicha G, Salamone JD (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletions: possible model of parkinsonian symptoms. J Neurosci 11:3822-3829
16. Jørgensen HA, Andreassen OA, Hole K (1994) The relationship between motor effects in rats following acute and chronic haloperidol treatment. Psychopharmacology 116:89-92
17. Kane JM (1992) Tardive dyskinesia. American Psychiatric Association, Washington, DC
18. Levy AD, See RD, Levin ED, Ellison GD (1987) Neuroleptic-induced oral movements in rats: methodological issues. Life Sci 41:1499-1506
19. Meredith GE, DeSouza IAJ, Hyde TM, Tipper G, Wong ML, Egan MF (2000) Persistent alterations in dendrites, spines and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J Neurosci 20:7798-7806
20. Molloy AM, Waddington JL (1984) Dopaminergic behaviour stereospecifically promoted by the D-1 agonist R-SK&F 38393 and selectively blocked by the D-1 antagonist SCH 23390. Psychopharmacology 82:409-410
21. 1-like dopamine receptors: molecular biology and psychopharmacology. In: Di Chiara G (ed) Handbook of pharmacology: dopamine in the CNS. Springer, Berlin Heidelberg New York, pp 121-158
22. Rosengarten H, Schwietzer JW, Friedhoff AJ (1983) Induction of oral dyskinesia in naïve rats by D-1 stimulation. Life Sci 33:2479-2482
23. 1 receptor mediates repetitive jaw movements in rats. Biol Psychiat 44:1178-1184
24. Rupniak NMJ, Jenner P, Marsden CD (1985) Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats. Psychopharmacology 85:71-79
25. Rupniak NMJ, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88:403-419
26. Salamone JD, Mayorga AJ, Trevitt JT, Cousins MS, Conlan A, Nawab A (1998) Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol 56:591-611
27. 4. Neuropsychopharmacology 7:261-284
28. Steinpreis RE, Salamone JD (1993) The effects of acute haloperidol and reserpine administration on vacuous chewing movements in three age groups of rats. Pharm Biochem Behav 46:405-409
29. Steinpreis RE, Baskin PP, Salamone JD (1993) Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine. Psychopharmacology 111:99-105
30. Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N (1990) Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102:474-478
31. Waddington JL (1989) Schizophrenia, affective psychoses and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms. Int Rev Neurobiol 31:297-353
32. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431-447
33. Waddington JL (1997) Rodent and other animal models of tardive dyskinesia during long-term neuroleptic drug administration: controversies and implications for the clinical syndrome. In: Yassa R, Nair NPV, Jeste DV (eds) Neuroleptic-induced movement disorders. Cambridge University Press, New York, pp 225-237
34. Waddington JL, Gamble SJ (1981) Prolonged dopamine receptor blockade in rats after termination of long-term depot fluphenazine. Lancet 1:1375-1376
35. Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530-532
36. Waddington JL, Molloy AG, O'Boyle KM, Youssef HA (1985) Spontaneous and drug-induced dyskinesias in rodents in relation to ageing and long-term neuroleptic treatment: relationship to tardive dyskinesia. In: Shagass C, Josiassen RC, Bridger W, Weiss K, Stoff D, Simpson GM (eds) Biological psychiatry. Elsevier, New York, pp 1151-1153
37. Waddington JL, Daly SA, Downes RP, Deveney AM, McCauley PG, O'Boyle KM (1995) Behavioural pharmacology of D-1-like dopamine receptors: further subtyping, new pharmacological probes and interactions with D-2-like receptors. Prog Neuro-Psychopharmacol Biol Psychiat 19:811-831